Literature DB >> 32628027

Structures and Biosynthetic Pathway of Pulvomycins B-D: 22-Membered Macrolides from an Estuarine Streptomyces sp.

Kyuho Moon1,2, Jinsheng Cui1, Eunji Kim1, Evan Setiawan Riandi1, So Hyun Park1, Woong Sub Byun1, Youngju Kal3, Jun Young Park3, Sunghoon Hwang1, Daniel Shin1, Jeongyoon Sun4, Ki-Bong Oh4, Sangwon Cha3, Jongheon Shin1, Sang Kook Lee1, Yeo Joon Yoon1, Dong-Chan Oh1.   

Abstract

Pulvomycins B-D (1-3) were discovered from an estuarine Streptomyces strain along with the known pulvomycin (4). The 22-membered macrocyclic lactone structures of 1-3 were determined based on the interpretation of NMR, UV, and MS data, the modified Mosher's method, and Kishi's bidentate chiral solvent NMR spectroscopy. Genomic analysis of the bacterial strain revealed the biosynthetic gene cluster of pulvomycin and enabled us to propose the trans-acyltransferase polyketide biosynthetic pathway. Pulvomycin D displayed potent cytotoxic activity against various cancer cell lines.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32628027     DOI: 10.1021/acs.orglett.0c01249

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  3 in total

1.  Ligiamycins A and B, Decalin-Amino-Maleimides from the Co-Culture of Streptomyces sp. and Achromobacter sp. Isolated from the Marine Wharf Roach, Ligia exotica.

Authors:  Hyung-Ju Lim; Joon Soo An; Eun Seo Bae; Eunji Cho; Sunghoon Hwang; Sang-Jip Nam; Ki-Bong Oh; Sang Kook Lee; Dong-Chan Oh
Journal:  Mar Drugs       Date:  2022-01-18       Impact factor: 5.118

2.  Total Synthesis of Pulvomycin D.

Authors:  Lukas Fritz; Sebastian Wienhold; Sabrina Hackl; Thorsten Bach
Journal:  Chemistry       Date:  2021-12-07       Impact factor: 5.020

3.  Antitumor Activity of Pulvomycin via Targeting Activated-STAT3 Signaling in Docetaxel-Resistant Triple-Negative Breast Cancer Cells.

Authors:  Woong Sub Byun; Eun Seo Bae; Jinsheng Cui; Hyen Joo Park; Dong-Chan Oh; Sang Kook Lee
Journal:  Biomedicines       Date:  2021-04-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.